| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/05/2003 | CN1100537C Agonists and antagonist for nicotinic acetylcholine receptors of insects to control endoparasites |
| 02/05/2003 | CN1100536C Composition for rectal administration |
| 02/05/2003 | CN1100535C Pharmaceutical agents for treatment of emesis |
| 02/05/2003 | CN1100533C Melatonin derivatives for usein terating desynchronization disorders |
| 02/05/2003 | CN1100532C Desquamation copositions contaiig salicylic acid and zwitterionic compounds |
| 02/05/2003 | CN1100531C Use of agonists of antagonist of P2 purinoceptors for prevention of glutamate evoked cytotoxicity |
| 02/04/2003 | WO2002014333A1 Phosphonocephem compound |
| 02/04/2003 | WO2002011734A1 Aqueous pharmaceutical compositions |
| 02/04/2003 | US6515198 Transgenic animals; calibration |
| 02/04/2003 | US6515173 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/04/2003 | US6515136 To the novel intermediates prepared by these methods. The biphenyl isoxazole sulfonamides prepared by the present methods are endothelin antagonists useful, inter alia, for the treatment of hypertension. |
| 02/04/2003 | US6515135 Aminoaryl oxazolidinone N-oxides |
| 02/04/2003 | US6515133 Certain diaryl imidazoles act as partial agonists or antagonists for NPY receptors, in particular NPY 5 receptors. They are of use, for example in treating loss of appetite. Such compounds bear aryl groups in the 2 position. |
| 02/04/2003 | US6515130 The invention relates to a process of preparing (S-(R*,S*))-beta -(((1-(1-oxo-3-(4-piperidinyl)propyl)-3-piperidinyl) carbonyl)amino)-3-pyridinepropanoic acid derivatives represented by the antagonists of the platelet fibrinogen |
| 02/04/2003 | US6515129 A pharmaceutical composition which comprises, a cyclic imide derivative represented by the general formula (I): present invention relates to an aminopeptidase N inhibitor or an angiogenesis inhibitor, modulates production of tumor necrosis |
| 02/04/2003 | US6515124 Dehydroamino acids |
| 02/04/2003 | US6515117 C-aryl glucoside SGLT2 inhibitors and method |
| 02/04/2003 | US6515116 Method of preparing form II crystals of clarithromycin |
| 02/04/2003 | US6515028 Glucamine compounds for treating hepatitis virus infections |
| 02/04/2003 | US6515027 Substituted benzanilides as CCR5 receptors ligands, antiinflammatory agents and antiviral agents |
| 02/04/2003 | US6515025 Use of ethynyl alanine amino diol compounds to inhibit enzymatic conversion of angiotensinogen to angiotensin I |
| 02/04/2003 | US6515022 Use of inhaled retinoids in the treatment of lung diseases |
| 02/04/2003 | US6515021 The compounds according to the invention have pronounced activity in the fields of cell differentiation and cell proliferation |
| 02/04/2003 | US6515020 Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders |
| 02/04/2003 | US6515019 Methods of providing symptomatic and prophylactic treatment for medical and neurological conditions |
| 02/04/2003 | US6515018 Synergistic compositions for lycopene and Vitamin E for the prevention of LDL oxidation |
| 02/04/2003 | US6515017 Polyamino acid conjugated paclitaxel or docetaxel have increased water solubility, efficacy and accumulation within a tumor |
| 02/04/2003 | US6515016 Treating or preventing multiple sclerosis, by administering an antimicrotubule agent; treating various other inflammatory diseases |
| 02/04/2003 | US6515015 Antidiabetic agents based on aryl and heteroarylacetic acids |
| 02/04/2003 | US6515012 Reacting 3-benzoylthio-2-methylpropionoic acid chloride with 4-phenylthio-L-proline; hypotnsive agents |
| 02/04/2003 | US6515011 Anticoagulants |
| 02/04/2003 | US6515010 Carvedilol methanesulfonate |
| 02/04/2003 | US6515009 Therapeutic inhibitor of vascular smooth muscle cells |
| 02/04/2003 | US6515008 Formulation of H2- receptor antagonist cimetidine in liquid formulations |
| 02/04/2003 | US6515007 Methods for managing scalp conditions |
| 02/04/2003 | US6515006 Ophthalmic formulation which modulates dilation |
| 02/04/2003 | US6515005 Substituted azole derivatives as inhibitors of corticotropin releasing factor |
| 02/04/2003 | US6515004 Useful in the treatment of Alzheimer's disease, chemotherapy-induced alopecia, and cardiovascular disease |
| 02/04/2003 | US6515003 Useful in the treatment of diseases related to lipid and carbohydrate metabolism |
| 02/04/2003 | US6515002 Compounds and compositions for treating C1s-mediated diseases and conditions |
| 02/04/2003 | US6515001 IL-8 receptor ligands-drugs for inflammatory and autoimmune diseases |
| 02/04/2003 | US6514999 A substance which increases Dopamine concentration in the synaptic cleft of the neurons of the brain, in combination with an effective amount of a local anesthetic of the anilide group or derivatives thereof |
| 02/04/2003 | US6514997 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/04/2003 | US6514996 Phosphodiesterase (PDE) IV inhibitors; used to treat inflammatory allergic diseases, autoimmune diseases, diseases of the central nervous system, insulin-resistant diabetes; wounds; AIDS, and the like. |
| 02/04/2003 | US6514994 Levobupivacaine and its use |
| 02/04/2003 | US6514993 Serotonin 5-HT1A and dopamin D2 receptor ligands |
| 02/04/2003 | US6514992 Caspases and apoptosis |
| 02/04/2003 | US6514989 Aromatic and heteroaromatic substituted 1,2,4-triazolo pyridine derivatives |
| 02/04/2003 | US6514986 Chiral fluoroquinolone arginine salt forms |
| 02/04/2003 | US6514985 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; exhibit antiviral and antitumor properties |
| 02/04/2003 | US6514984 Human non-pancreatic secretory phospholipase A2 inhibitors |
| 02/04/2003 | US6514983 Inhibitors of the nucleic enzyme poly(adenosine 5'-diphospho-ribose)polymerase |
| 02/04/2003 | US6514982 CRF receptor antagonists and methods relating thereto |
| 02/04/2003 | US6514980 Nucleoside analogs in combination therapy of herpes simplex infections |
| 02/04/2003 | US6514979 For treating a viral infection, such as an HIV-1 infection |
| 02/04/2003 | US6514977 For treating p38 kinase mediated disorders |
| 02/04/2003 | US6514976 Arylpiperazines having activity at the serotonin 1A receptor |
| 02/04/2003 | US6514975 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof |
| 02/04/2003 | US6514974 Pyrido-, pyrimido-, pyridazo- and pyrazo- pyridazines having angiogenesis inhibiting activity |
| 02/04/2003 | US6514973 Treatment of transmethylation disorders comprising one or more compounds selected from phosphatidyl serines, methyl transporters, and methyl and methylene donors with exipient |
| 02/04/2003 | US6514971 Cinnoline derivatives and use as medicine |
| 02/04/2003 | US6514970 Urotensin-II receptor antagonists |
| 02/04/2003 | US6514968 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising |
| 02/04/2003 | US6514965 Substituted 1-benzazepines and derivatives thereof |
| 02/04/2003 | US6514964 Treating diseases, conditions or disorders mediated by integrin receptors, such as vitronectin and fibronectin receptors |
| 02/04/2003 | US6514963 Methods for the inhibition of egg production in trematodes |
| 02/04/2003 | US6514962 Beta -lactam antibiotic having an esterified carboxy group directly coupled to the nucleus is mixed with a salt of phosphoric acid and oil, a dramatic improvement occurs in its stability |
| 02/04/2003 | US6514961 Such as anxiety and all forms of epilepsy, particularly in humans |
| 02/04/2003 | US6514960 Use of bismuth subgallate in inhibition of production of nitric oxide synthase |
| 02/04/2003 | US6514959 Microbicides |
| 02/04/2003 | US6514958 Dosage unit comprising tibolone and a water insoluble starch product is contained in a humid atmosphere of 50 to 70% relative humidity until administration |
| 02/04/2003 | US6514957 Method of alleviating the violence and stimulating the appetite of stag in the puberty age of the fall and method of promoting the growth of stag's horn |
| 02/04/2003 | US6514956 For treating diseases associated with progestogen dependence and for fertility control, abortion or contraception and for anticancer use |
| 02/04/2003 | US6514953 Calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamate |
| 02/04/2003 | US6514952 For the treatment and prophylaxis of diseases which are caused by an undesired extent of leucocyte adhesion and/or leucocyte migration such as rheumatoid arthritis or allergic disorders |
| 02/04/2003 | US6514951 LL-F28249 alpha-lambda or a 23-oxo or 23-imino derivative of |
| 02/04/2003 | US6514949 Administering A2A adenosine agonist in combination with an effective amount of a Type IV phosphodiesterase inhibitor for treatment of inflammation caused by an ischemia/reperfusion injury |
| 02/04/2003 | US6514945 Azalide antibiotic compositions |
| 02/04/2003 | US6514934 For treating sexual dysfunctions in males and females |
| 02/04/2003 | US6514756 Human myoblast cell lines and their uses |
| 02/04/2003 | US6514754 Of herpesvirus of turkeys (HVT) inserted in a non-essential region of the vector; may be manipulated to provide vaccines |
| 02/04/2003 | US6514745 Oncoprotein protein kinase |
| 02/04/2003 | US6514726 Aspergillus fumigatus acetyl coenzyme-A carboxylase genes and polypeptides and uses thereof |
| 02/04/2003 | US6514712 Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas |
| 02/04/2003 | US6514686 Alzheimer's disease |
| 02/04/2003 | US6514544 Beverage for increasing the body's capacity to break down alcohol and method thereof |
| 02/04/2003 | US6514537 Citric acid, magnesium hydroxide, water |
| 02/04/2003 | US6514536 Drug preparations for treating sexual dysfunction |
| 02/04/2003 | US6514534 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 02/04/2003 | US6514531 Controlled-release dosage forms comprising zolpidem or a salt thereof |
| 02/04/2003 | US6514529 A compressed tablet of antibacterial oxazolidinone selected from the group consisting of linezolid, eperezolid and (S)-N-((3-(3-fluoro-4-(tetrahydro-2H-thiopyran-4-yl)phenyl-2-o xo-5-oxazolidinylmethyl)acetamide S,S-dioxide |
| 02/04/2003 | US6514527 Compositions comprising a mixture of bioflavonols |
| 02/04/2003 | US6514526 Coated starch capsules and a process for producing them |
| 02/04/2003 | US6514525 Sustained release; mixture of non-steroid antiinflammatory drug, prostaglandin and excipient |
| 02/04/2003 | US6514524 Improved absorption of hydrophilic ingredients because of particular excipients; calcium 3-acetylamino-1-propane sulfonate (calcium acamprosate); polysorbates, fatty ethers or esters of PEG, polyglycolysed glycerides |
| 02/04/2003 | US6514520 Containing about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid, including salts such as disodium EDTA; especially the antihistamines loratadine, descarboethoxyloratadine, and azatadine |
| 02/04/2003 | US6514519 1-octadecyl-2-methyl-sn-glycero-3-phosphocholine; oral administration |
| 02/04/2003 | US6514516 Local anesthetic and a biocompatible controlled release material consisting of polyanhydrides, copolymers of lactic acid and glycolic acid, poly(lactic) acid, poly(glycolic) acid, polyesters, polyorthoesters, proteins, polysaccharides |
| 02/04/2003 | US6514507 Administering 10-Hydroxy-2-decenoic acid and derivatives for stimulating epidermal renewal and/or combating intrinsic aging of the skin |
| 02/04/2003 | US6514499 Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof |